Skip to content
Cathie Wood Says Her Company Is Testing A More Aggressive Strategy That Would Be “ARK On Steroids”


Catherine Wood, Managing Director of ARK Investment Management LLC, speaks at the Milken Institute Global Conference in Beverly Hills, Calif. On Monday, October 18, 2021.

Kyle Grillot | Bloomberg | Getty Images

This is breaking news. Please check for updates.

Cathie Wood – known for its aggressive innovation ETFs – said Ark Invest is internally testing a fund that incorporates short selling into major benchmarks.

“We have in-house, employees only, we’re testing a portfolio but it’s really Ark on steroids,” Wood told CNBC’s “Squawk Box” on Wednesday.

“We want to test it on ourselves first and make sure that everyone is keeping an eye on that 5 year time horizon… and not paying attention from day to day,” she added.

Wood’s flagship fund, Ark Innovation ETF, is down nearly 15% in 2021.


cnbc Business

Not all news on the site expresses the point of view of the site, but we transmit this news automatically and translate it through programmatic technology on the site and not from a human editor.